5-hydroxy-3,6,7,8,3',4'-hexamethoxyflavone has been researched along with dinoprostone in 1 studies
Studies (5-hydroxy-3,6,7,8,3',4'-hexamethoxyflavone) | Trials (5-hydroxy-3,6,7,8,3',4'-hexamethoxyflavone) | Recent Studies (post-2010) (5-hydroxy-3,6,7,8,3',4'-hexamethoxyflavone) | Studies (dinoprostone) | Trials (dinoprostone) | Recent Studies (post-2010) (dinoprostone) |
---|---|---|---|---|---|
25 | 0 | 9 | 29,105 | 1,346 | 6,357 |
Protein | Taxonomy | 5-hydroxy-3,6,7,8,3',4'-hexamethoxyflavone (IC50) | dinoprostone (IC50) |
---|---|---|---|
Prostaglandin E2 receptor EP1 subtype | Homo sapiens (human) | 0.0155 | |
Prostaglandin E2 receptor EP4 subtype | Homo sapiens (human) | 0.0031 | |
Prostaglandin E2 receptor EP4 subtype | Rattus norvegicus (Norway rat) | 0.0021 | |
Prostaglandin E2 receptor EP3 subtype | Homo sapiens (human) | 0.002 | |
Prostaglandin E2 receptor EP2 subtype | Homo sapiens (human) | 0.0087 | |
Prostacyclin receptor | Homo sapiens (human) | 0.26 | |
Prostaglandin E2 receptor EP2 subtype | Rattus norvegicus (Norway rat) | 0.0052 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cho, YS; Choi, YH; Jeong, JW; Jeong, YK; Kang, BW; Kim, GY; Kim, JI; Kim, KS; Kim, MJ; Lee, HH; Park, JU; Seo, KI; Seo, MJ | 1 |
1 other study(ies) available for 5-hydroxy-3,6,7,8,3',4'-hexamethoxyflavone and dinoprostone
Article | Year |
---|---|
Anti-inflammatory effects of 5-hydroxy-3,6,7,8,3',4'-hexamethoxyflavone via NF-κB inactivation in lipopolysaccharide-stimulated RAW 264.7 macrophage.
Topics: Animals; Anti-Inflammatory Agents; Cell Death; Cell Line; Cell Survival; Cyclooxygenase 2; Dinoprostone; Flavones; Interleukin-1beta; Lipopolysaccharides; Macrophages; Mice; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Protective Agents; Signal Transduction; Tumor Necrosis Factor-alpha | 2014 |